These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 18181555

  • 1. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.
    Thommes M, Kleinebudde P.
    AAPS PharmSciTech; 2007 Nov 09; 8(4):E95. PubMed ID: 18181555
    [Abstract] [Full Text] [Related]

  • 2. Multiple batch manufacturing of theophylline pellets using the wet-extrusion/spheronization process with κ-carrageenan as pelletisation aid.
    Krueger C, Thommes M.
    Pharm Dev Technol; 2013 Feb 09; 18(1):225-35. PubMed ID: 22780876
    [Abstract] [Full Text] [Related]

  • 3. Effect of drying on extruded pellets based on kappa-carrageenan.
    Thommes M, Blaschek W, Kleinebudde P.
    Eur J Pharm Sci; 2007 Jun 09; 31(2):112-8. PubMed ID: 17448646
    [Abstract] [Full Text] [Related]

  • 4. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C, Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2013 Nov 09; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [Abstract] [Full Text] [Related]

  • 5. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
    Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2006 May 09; 63(1):68-75. PubMed ID: 16325384
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The behavior of different carrageenans in pelletization by extrusion/spheronization.
    Thommes M, Kleinebudde P.
    Pharm Dev Technol; 2008 May 09; 13(1):27-35. PubMed ID: 18300097
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development and characterization of enteric-coated immediate-release pellets of aceclofenac by extrusion/spheronization technique using kappa-carrageenan as a pelletizing agent.
    Kilor VA, Sapkal NP, Awari JG, Shewale BD.
    AAPS PharmSciTech; 2010 Mar 09; 11(1):336-43. PubMed ID: 20195805
    [Abstract] [Full Text] [Related]

  • 13. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets.
    Pund S, Joshi A, Vasu K, Nivsarkar M, Shishoo C.
    Int J Pharm; 2010 Mar 30; 388(1-2):64-72. PubMed ID: 20035851
    [Abstract] [Full Text] [Related]

  • 14. Analysis of particle kinematics in spheronization via particle image velocimetry.
    Koester M, Thommes M.
    Eur J Pharm Biopharm; 2013 Feb 30; 83(2):307-14. PubMed ID: 23000404
    [Abstract] [Full Text] [Related]

  • 15. A Quality by Experimental Design Approach to Assess the Effect of Formulation and Process Variables on the Extrusion and Spheronization of Drug-Loaded Pellets Containing Polyplasdone® XL-10.
    Saripella KK, Loka NC, Mallipeddi R, Rane AM, Neau SH.
    AAPS PharmSciTech; 2016 Apr 30; 17(2):368-79. PubMed ID: 26169900
    [Abstract] [Full Text] [Related]

  • 16. Production variables affecting characteristics of pellets in melt pelletization with wax combination in a laboratory scale spheronizer.
    Biswal S, Sahoo J, Murthy PN, Giradkar RP, Das S, Avari JG.
    Acta Pharm; 2009 Jun 30; 59(2):199-210. PubMed ID: 19564144
    [Abstract] [Full Text] [Related]

  • 17. Spheronization of small extrudates containing kappa-carrageenan.
    Yoo A, Kleinebudde P.
    J Pharm Sci; 2009 Oct 30; 98(10):3776-87. PubMed ID: 19130471
    [Abstract] [Full Text] [Related]

  • 18. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P, Steffens KJ, Kleinebudde P.
    Drug Dev Ind Pharm; 2009 Nov 30; 35(11):1325-32. PubMed ID: 19832632
    [Abstract] [Full Text] [Related]

  • 19. Development of a controlled release formulation by continuous twin screw granulation: Influence of process and formulation parameters.
    Vanhoorne V, Vanbillemont B, Vercruysse J, De Leersnyder F, Gomes P, Beer TD, Remon JP, Vervaet C.
    Int J Pharm; 2016 May 30; 505(1-2):61-8. PubMed ID: 27041123
    [Abstract] [Full Text] [Related]

  • 20. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY, Yap HN, Chaw CS.
    Drug Dev Ind Pharm; 2014 Mar 30; 40(3):418-24. PubMed ID: 23480532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.